Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT00135616
Other study ID # xd01
Secondary ID
Status Active, not recruiting
Phase Phase 4
First received August 25, 2005
Last updated April 27, 2007
Start date March 2005
Est. completion date March 2008

Study information

Verified date April 2007
Source Hopital Antoine Beclere
Contact n/a
Is FDA regulated No
Health authority France: Ministry of HealthFrance: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare efficacy and morbidity following the placement of two types of suburethral slings in women presenting with stress urinary incontinence: TVT and TVT-O.


Description:

Urinary stress incontinence (USI) is a frequent pathology in women. Surgical treatment is required in 30 to 50% of women presenting with USI. Several surgical techniques are currently available.

At the present time, the placement of suburethral slings is one of the most efficient techniques. Furthermore, the placement of a suburethral sling is known to be associated with a low rate of complications.

Currently, two approaches are available for the placement of a suburethral sling: retropubic approach (TVT) and trans-obturator approach (TVT-O). The efficacy of these two approaches seem equivalents. However, the morbidity related to these two techniques is probably different. In retrospective studies, the retropubic approach is associated with a higher rate of bladder perforation. On the other hand, the trans-obturator approach is supposed to be associated with a higher rate of post-operative pain.

Thus, the purpose of this study is to compare efficacy and morbidity following the placement of two types of suburethral slings in women presenting with stress urinary incontinence: TVT and TVT-O.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 180
Est. completion date March 2008
Est. primary completion date
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 95 Years
Eligibility Inclusion Criteria:

- Woman over 18 years old

- Clinical diagnosis of stress urinary incontinence requiring surgical management

- Must be able to read and sign the consent

Exclusion Criteria:

- Pregnancy

- Anti-coagulant treatment

- Isolated overactive bladder syndrome

- Genital prolapse requiring surgical treatment

- Concomitant hysterectomy

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
surgical placement of a suburethral sling tvt or tvt-o


Locations

Country Name City State
France CHU Amiens Amiens
France Centre Hospitalier Universitaire Angers
France CHU Pellegrin Bordeaux
France Hopital Saint Andre Bordeaux
France CH Chambery Chambery
France Hopital Antoine Beclere Clamart
France Hôtel Dieu Clermont-Ferrand
France CH Dunkerque Dunkerque
France Centre Hospitalier Paul Ardier Issoire
France Chu Nancy Nancy
France CH Caremeau Nimes
France Hopital Diaconesses Croix Saint Simon Paris
France CH Rennes Rennes
France CH Rouen Rouen

Sponsors (1)

Lead Sponsor Collaborator
Hopital Antoine Beclere

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary pre operative complication: rate of bladder perforation
Primary post operative complication: rate of post-operative pain
Secondary efficacy: disparation of urinary incontinence
Secondary safety: sexual behaviour
See also
  Status Clinical Trial Phase
Completed NCT02001714 - Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms N/A
Not yet recruiting NCT00523068 - Pharmacological vs Surgical Treatment for Mixed Incontinence Phase 4
Completed NCT00904969 - A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence N/A
Completed NCT00190814 - Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge. Phase 3
Completed NCT00190827 - Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine) Phase 3
Terminated NCT00247286 - Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial. Phase 4
Completed NCT01959347 - Combined Treatment for Mixed Incontinence Phase 3
Completed NCT00244296 - To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms Phase 4
Not yet recruiting NCT05570071 - A Study of the Use of Vaginal Radiofrequency Therapy in Treatment of SUI. N/A
Completed NCT02334878 - Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence Phase 3
Completed NCT01382602 - Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study Phase 3
Completed NCT03296462 - Hip External Rotation Physical Therapy Trial N/A
Recruiting NCT02750878 - Surgical Consent Process for Trans-obturator Tape Slings. N/A
Completed NCT02296099 - Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence Phase 4
Completed NCT02599051 - Transobturator Verus Single Incision Slings N/A
Completed NCT00138749 - An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence. Phase 2
Terminated NCT03614611 - Canadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence N/A
Completed NCT03722719 - The Knack on Female Stress Urinary Incontinence N/A
Active, not recruiting NCT02275728 - Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence N/A
Terminated NCT01358214 - Quality of Life After Tension Free Transvaginal Sling / Tape Operation With a Titanized Surgical Tape (TiLOOP® Tape) N/A